Pelvic and paraortic lymph nodal status in advanced ovarian cancer and survival

Gynecologic Oncology

Volumn 74, Issue 1, 1999, Pages 7-11

  Parazzini, Fabio ^a   Valsecchi, Grazia ^a   Bolis, Giorgio ^b   Guarnerio, Paolo ^a   Reina, Simona ^b   Polverino, Giampiero ^b   Silvestri, Daniela ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVARY CANCER; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRIORITY JOURNAL;

EID: 0032814625     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5397     Document Type: Article

References (11)

1. Burghard E, Girardi F, Lahousen M, Tamussino K, Stettner H. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol. 40:1991;103-106.
2. Onda T, Yoshikawa H, Yokota H, Yasugi T, Taketani Y. Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. Cancer. 78:1996;903-908.
3. Chen S S. Survival of ovarian carcinoma with or without lymph node metastasis. Gynecol Oncol. 27:1987;368-372.
4. DiRe F, Fontanelli R, Raspagliesi F, DiRe E. Pelvic and paraaortic lymphadenectomy in cancer of the ovary. Bailliere's Clin Obstet Gynecol. 3:1989;131-142.
5. Hacker N F. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer - therapeutic advance or surgical folly. Gynecol Oncol. 56:1995;325-327.
6. Benedetti Panici P, Scambia G, Baiocchi G, Greggi S, Mancuso S. Technique and feasibility of radical paraaortic and pelvic lymphadenectomy for gynecologic malignancies. A prospective study. Int J Gynecol Cancer. 1:1991;133-140.
7. Scarabelli C, Gallo A, Visentin M C, Canzonieri V, Carbone A, Zarrelli A. Systematic pelvic and para-aortic lymphadenectomy in advanced ovarian cancer patients with no residual intraperitoneal disease. Int J Gynecol Cancer. 7:1997;18-26.
8. Bolis G, Favalli G, Danese G, Zanaboni F, Mangili G, Scarabelli C, Tateo S, Valsecchi G, Scarfone G, Richiardi A, Frigerio L, Malpignano M, Villa A, Parazzini F. Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer. J Clin Oncol. 15:1997;1938-1944.
9. Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
10. Peto R, Pike M C, Armitage P, Breslow N E, Cox D R, Howard S V, Mantel N, McPherson K, Peto J, Smith P G. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 35:1977;1-39.
11. Cox D R. Regression models and life-tables. J Royal Stat Soc B. 34:1972;187-220.